{"id":472710,"date":"2021-04-07T08:33:20","date_gmt":"2021-04-07T12:33:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=472710"},"modified":"2021-04-07T08:33:20","modified_gmt":"2021-04-07T12:33:20","slug":"chemocentryx-to-host-virtual-rd-day-on-april-14-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/","title":{"rendered":"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">MOUNTAIN VIEW, Calif., April  07, 2021  (GLOBE NEWSWIRE) &#8212; ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host a virtual R&amp;D Day on Wednesday, April 14, 2021 beginning at 12:30 p.m. ET. The event will feature a panel of key opinion leaders, a testimonial from a patient living with ANCA-associated vasculitis and members of the ChemoCentryx Management team. The event will focus on the Company\u2019s upcoming milestones and developments in key pipeline programs.<\/p>\n<p>\n        <strong>Presenters:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:0.1pt;margin-bottom:0.1pt\">Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx<\/li>\n<li style=\"margin-top:0.1pt;margin-bottom:0.1pt\">Tausif (\u201cTosh\u201d) Butt, Executive Vice President and Chief Operating Officer of ChemoCentryx<\/li>\n<li>David Jayne, M.D., Director of the Vasculitis and Lupus Service, Addenbrooke\u2019s Hospital in Cambridge<\/li>\n<li style=\"margin-top:0.1pt;margin-bottom:0.1pt\">Peter A. Merkel, M.D., MPH, Chief of Rheumatology and Professor of Medicine and Epidemiology at the University of Pennsylvania<\/li>\n<li style=\"margin-top:0.1pt;margin-bottom:0.1pt\">Glen Massie, Patient living with ANCA-associated vasculitis<\/li>\n<\/ul>\n<p>\n        <strong>Virtual R&amp;D Day Information:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:0.1pt\">Date: Wednesday, April 14, 2021<\/li>\n<li style=\"margin-bottom:0.1pt\">Time: 12:30pm \u2013 3:00pm ET<\/li>\n<li style=\"margin-top:0.1pt;margin-bottom:0.1pt\">Live webcast link: <a href=\"https:\/\/wsw.com\/webcast\/cc\/ccxi2\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/cc\/ccxi2\/<\/a><\/li>\n<\/ul>\n<p>Following completion of the live event, an archived webcast can be accessed through the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8UPjxbaEYP3IdSnBo6oN4vjrK3SYMKOjWeg_7O2-VWYDZbMhk8drEMRwq8_Yz5v77QfbeZ2HrK5L7AipGsQEH_vTMplvioE4PPifWOX6rik=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ChemoCentryx.com<\/a>, approximately two hours following the event. The archived webcast will remain available on the Company\u2019s website for 60 days.<\/p>\n<p>\n        <strong>About ChemoCentryx<\/strong>\n      <\/p>\n<p>ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx\u2019s lead drug candidate, avacopan (CCX168), successfully completed a pivotal Phase III trial in ANCA-associated vasculitis and a New Drug Application is under review by the U.S. Food and Drug Administration. Avacopan is also in late stage clinical development for the treatment of severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G).<\/p>\n<p>ChemoCentryx also has early stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.<\/p>\n<p>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>Susan M. Kanaya<br \/>Executive Vice President,<br \/>Chief Financial and Administrative Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QCpuVTF-baMZcJtEllOgYkdqzndWWTGH5uoNtl4YsFs-eywQ90avsJBphRm9cMnWV_P_CD3d8LRTsHzP8eeXRZPBGWxIa3rwcnTOsVdbK64=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investor@chemocentryx.com<\/a>\u00a0<\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Stephanie Tomei<br \/>408.234.1279<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WOqencMazi2Me9l5N1kesTguUWoZu61ZC_nqGcI6_5j8WCnuQaPD_8EsbrUcap0pEk5xvMtfNd432M90LjBenhT_o4HBEhoDFXU3KDz-WWs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">media@chemocentryx.com<\/a>\u00a0<\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Burns McClellan, Inc.<br \/>Lee Roth<br \/>212.213.0006<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ew6sKE_8sIyVOlVaMCr5NlMvXg12JfEjVZmQqdfRu5sYAVVvDw1HzInFHDUQRo25WPXCBseOfbWEO5VYp9_WNA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lroth@burnsmc.com<\/a>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c948a3be-ec1d-4405-8268-924fbbaf2ce0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MOUNTAIN VIEW, Calif., April 07, 2021 (GLOBE NEWSWIRE) &#8212; ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host a virtual R&amp;D Day on Wednesday, April 14, 2021 beginning at 12:30 p.m. ET. The event will feature a panel of key opinion leaders, a testimonial from a patient living with ANCA-associated vasculitis and members of the ChemoCentryx Management team. The event will focus on the Company\u2019s upcoming milestones and developments in key pipeline programs. Presenters: Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx Tausif (\u201cTosh\u201d) Butt, Executive Vice President and Chief Operating Officer of ChemoCentryx David Jayne, M.D., Director of the Vasculitis and Lupus Service, Addenbrooke\u2019s Hospital in Cambridge Peter A. Merkel, M.D., MPH, Chief of Rheumatology &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-472710","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MOUNTAIN VIEW, Calif., April 07, 2021 (GLOBE NEWSWIRE) &#8212; ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host a virtual R&amp;D Day on Wednesday, April 14, 2021 beginning at 12:30 p.m. ET. The event will feature a panel of key opinion leaders, a testimonial from a patient living with ANCA-associated vasculitis and members of the ChemoCentryx Management team. The event will focus on the Company\u2019s upcoming milestones and developments in key pipeline programs. Presenters: Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx Tausif (\u201cTosh\u201d) Butt, Executive Vice President and Chief Operating Officer of ChemoCentryx David Jayne, M.D., Director of the Vasculitis and Lupus Service, Addenbrooke\u2019s Hospital in Cambridge Peter A. Merkel, M.D., MPH, Chief of Rheumatology &hellip; Continue reading &quot;ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T12:33:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021\",\"datePublished\":\"2021-04-07T12:33:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/\"},\"wordCount\":350,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/\",\"name\":\"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=\",\"datePublished\":\"2021-04-07T12:33:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/","og_locale":"en_US","og_type":"article","og_title":"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021 - Market Newsdesk","og_description":"MOUNTAIN VIEW, Calif., April 07, 2021 (GLOBE NEWSWIRE) &#8212; ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host a virtual R&amp;D Day on Wednesday, April 14, 2021 beginning at 12:30 p.m. ET. The event will feature a panel of key opinion leaders, a testimonial from a patient living with ANCA-associated vasculitis and members of the ChemoCentryx Management team. The event will focus on the Company\u2019s upcoming milestones and developments in key pipeline programs. Presenters: Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx Tausif (\u201cTosh\u201d) Butt, Executive Vice President and Chief Operating Officer of ChemoCentryx David Jayne, M.D., Director of the Vasculitis and Lupus Service, Addenbrooke\u2019s Hospital in Cambridge Peter A. Merkel, M.D., MPH, Chief of Rheumatology &hellip; Continue reading \"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-07T12:33:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021","datePublished":"2021-04-07T12:33:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/"},"wordCount":350,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/","name":"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=","datePublished":"2021-04-07T12:33:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMjU0MyM0MTA4NzIyIzIwMDY0MDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-host-virtual-rd-day-on-april-14-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ChemoCentryx to Host Virtual R&amp;D Day on April 14, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=472710"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472710\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=472710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=472710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=472710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}